Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,166.28
    -1,257.29 (-2.44%)
     
  • CMC Crypto 200

    1,305.71
    -90.83 (-6.47%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Credit data firm Experian raises annual outlook after strong quarter

(Reuters) -Experian raised its annual outlook on Thursday after the world's largest credit data company posted a 31% jump in its first-quarter revenue, driven by a faster-than-expected recovery as economies emerge from the fallout of the COVID-19 pandemic.

The company, which runs credit data checks for people and assists lenders in managing credit risks, said its credit comparison marketplace got a boost as more consumers applied for credit cards and personal loans amid flexible lending criteria.

UK-listed Experian said it now expects total revenue growth for the year to come in the range of 13% to 15%, with organic revenue growth seen at 9-11%. The company previously forecasted its revenue targets to climb up to 11-13% and organic growth to rise 7-9%.

Premarket indicators pegged a 3% rise in the shares of the blue-chip company ahead of the market's open.

ADVERTISEMENT

Experian said its clients have resumed acquisition activity in its business-to-business offering in North America, compared with very low levels in the crisis-hit 2020.

The company's free memberships reached 44 million.

Experian, which makes nearly two-thirds of its revenue from the North American market, said steady vaccination rollouts led to an uplift in authentication volumes in its health business.

(Reporting by Muvija M in Bengaluru, Editing by Sherry Jacob-Phillips)